Chemed (NYSE:CHE) Releases Earnings Results, Beats Estimates By $0.46 EPS

Chemed (NYSE:CHE) released its quarterly earnings data on Tuesday. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46, FiscalAI reports. The firm had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 30.64% and a net margin of 10.60%.The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter last year, the firm earned $4.27 earnings per share. Chemed updated its FY 2026 guidance to 25.000-25.750 EPS.

Chemed Price Performance

NYSE:CHE traded down $2.79 during mid-day trading on Thursday, hitting $536.57. The company’s stock had a trading volume of 40,401 shares, compared to its average volume of 222,086. Chemed has a fifty-two week low of $365.20 and a fifty-two week high of $551.68. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $7.12 billion, a price-to-earnings ratio of 26.90, a P/E/G ratio of 1.91 and a beta of 0.52. The stock has a fifty day moving average of $463.37 and a 200-day moving average of $435.25.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. Chemed’s payout ratio is presently 13.08%.

Wall Street Analyst Weigh In

CHE has been the topic of a number of recent research reports. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday. Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Royal Bank Of Canada reaffirmed a “sector perform” rating on shares of Chemed in a research report on Thursday. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $480.25.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The SEC filing for this sale provides additional information. 3.33% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Chemed

Several institutional investors have recently added to or reduced their stakes in CHE. Los Angeles Capital Management LLC bought a new stake in Chemed during the fourth quarter worth about $26,000. Global Retirement Partners LLC raised its stake in shares of Chemed by 200.0% in the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after acquiring an additional 58 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the last quarter. Employees Retirement System of Texas acquired a new position in shares of Chemed in the 3rd quarter worth approximately $64,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in shares of Chemed by 5,333.3% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company’s stock worth $73,000 after acquiring an additional 160 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.